Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 71335-3070

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 71335-3070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\users\ra\desktop\1.jpg (5a5eca60 Figure 01)

This text appears to be a list of different blood pressure values and medications. It includes details such as SBP (systolic blood pressure) measurements, various medication names and dosages, including Valsartan-HCTZ and Hydrochlorothiazide, and also mentions baseline SBP values. The text may be part of a medical report or study involving blood pressure management.*

FDA Label Image

C:\users\ra\desktop\2.jpg (5a5eca60 Figure 02)

This is a list indicating blood pressure readings and medication dosages. The text suggests a baseline Diastolic Blood Pressure (DBP) of 105 mmHg and the use of Valsartan-HCTZ tablets with 320/25 mg dosage. Additionally, it includes a reference to Valsartan 320 mg tablets and Hydrochlorothiazide 25 mg tablets. The values 920, 95, and 100 may signify measurements or other data related to the study or treatment.*

FDA Label Image

C:\users\ra\desktop\3.jpg (5a5eca60 Figure 03)

This text appears to be a table showing blood pressure values for different measurements with and without medication intervention. It includes information on Valsartan-HCTZ, Valsartan, Hydrochlorothiazide, and Placebo at various blood pressure levels. The values seem to be in the range of 140 to 180 mmHg.*

FDA Label Image

C:\users\ra\desktop\4.jpg (5a5eca60 Figure 04)

This text appears to be a list of different medications and their dosages, specifically Valsartan-Hydrochlorothiazide combination at 320/25 mg, Valsartan standalone at 320 mg, Hydrochlorothiazide standalone at 25 mg, and a placebo. It also mentions some numerical values in relation to Baseline Diastolic Blood Pressure (DBP) measurements.*

FDA Label Image

C:\users\ra\desktop\5.jpg (5a5eca60 Figure 05)

FDA Label Image

C:\users\ra\desktop\6.jpg (5a5eca60 Figure 06)

FDA Label Image

Label (Lbl713353070)

Each tablet contains 320 mg of Valsartan and 12.5 mg of Hydrochlorothiazide. The usual dosage information can be accessed by scanning the package insert QR code. Pharmacists are advised to dispense the Medication Guide for Hydrochlorothiazide tablets to each patient. The tablets should be stored at 20°C to 25°C (68°F to 77°F), with permitted excursions to 15°C to 30°C (59°F to 86°F). Protect from moisture and keep in a tight container. This product is intended for prescription use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.